672
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program

, , , , , , & show all
Pages 136-143 | Received 22 Sep 2014, Accepted 16 Feb 2015, Published online: 21 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sol Moe Lee, Jae Wook Hyeon, Soo-Jin Kim, Heebal Kim, Ran Noh, Seonghan Kim, Yeong Seon Lee & Su Yeon Kim. (2019) Sensitivity and specificity evaluation of multiple neurodegenerative proteins for Creutzfeldt-Jakob disease diagnosis using a deep-learning approach. Prion 13:1, pages 141-150.
Read now
Qi Shi, Wei Zhou, Cao Chen, Chen Gao, Kang Xiao, Jing Wang, Bao-Yun Zhang, Yuan Wang, Feng Zhang & Xiao-Ping Dong. (2016) Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016. Prion 10:6, pages 484-491.
Read now

Articles from other publishers (3)

Yu Kong, Zhongyun Chen, Qi Shi, Ya Zuo & Jing Zhang. (2023) Clinical Correlates of Cerebrospinal Fluid 14-3-3 Protein in Non-Prion Rapid Progressive Dementia. Journal of Alzheimer's Disease 91:1, pages 263-272.
Crossref
Neil Watson, Jean-Philippe Brandel, Alison Green, Peter Hermann, Anna Ladogana, Terri Lindsay, Janet Mackenzie, Maurizio Pocchiari, Colin Smith, Inga Zerr & Suvankar Pal. (2021) The importance of ongoing international surveillance for Creutzfeldt–Jakob disease. Nature Reviews Neurology 17:6, pages 362-379.
Crossref
Chang Qi, Jia-Tang Zhang, Wei Zhao, Xiao-Wei Xing & Sheng-Yuan Yu. (2020) Sporadic Creutzfeldt-Jakob Disease: A Retrospective Analysis of 104 Cases. European Neurology 83:1, pages 65-72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.